LGC AXIO Proficiency Testing Schemes 2027
Samples Available Sample Code
Quantity of Matrix
Matrix
Analytes
PT-QZ-01+02
2x 10ml
Blood matrix
Sample 1: Participants will be asked to identify up to 4 drugs relevant to forensic toxicology. Sample 2: Quantification of a known drug (full identity or generic classification). Drug quantification Sample 3A: Morphine, Methadone, Amphetamine Diazepam. Sample 3B: Citalopram, Codeine, Amitriptyline, Tramadol Quantification of alcohol and fluoride in a blood sample Interpretation of a case study (with analytical data, and a scenario or witness statement) to determine the potential blood alcohol level at a given time Participants are asked to quantify/identify a range of new psychoactive substances (NPS). Two substances are named and are for quantification and a further two substances are not named and are to be identified by screening (quantification results may also be included) Participants are asked to screen for synthetic cannabinoids and identify one of the most common synthetic cannabinoids Participants are asked to identify up to 4 drugs or metabolites relevant to forensic toxicology A urine sample specifically for New Psychoactive Substance screening and may include synthetic cannabinoids. Up to two Drug quantification Sample 10A: Oxycodone, Pregabalin, MDMA and Mirtazapine Sample 10B: Loratidine, Gabapentin, Quetiapine and Valproate substances may be present. No interpretation is required
PT-QZ-03
10ml
Blood matrix
PT-QZ-04
10ml
Blood matrix
PT-QZ-05-VIRTUAL
Paper exercise
PT-QZ-06
10ml
Blood matrix
PT-QZ-07
10ml
Blood matrix
PT-QZ-08
10ml
Urine
PT-QZ-09
10ml
Urine
PT-QZ-10
10ml
Blood matrix
Download Application Form Download Scheme Description
lgcstandards.com/AXIO-PT 131
Made with FlippingBook Ebook Creator